ABRA (actin binding Rho activating protein) is a cytoplasmic protein that functions as a regulator of serum response factor (SRF)-dependent transcription through activation of the Rho-actin signaling pathway. The protein acts as an actin binding factor that promotes nuclear translocation of MKL1 or MKL2 transcriptional cofactors, thereby controlling gene expression downstream of Rho signaling. ABRA is particularly important in vascular biology: it plays a critical role in arteriogenesis by regulating actin polymerization and maturation during collateral vessel formation 1. During arterial occlusion, ABRA functions alongside other actin-binding proteins (cofilin, thymosin beta 4) to facilitate the phenotypic switch of vascular smooth muscle cells from contractile to synthetic and proliferative states, enabling compensatory vascular remodeling and new tissue production 1. The protein localizes to the actin cytoskeleton and plasma membrane, where it organizes actin dynamics and regulates positive signals through the Rho pathway and mitogen-activated kinases. While no direct disease associations are explicitly documented in the provided abstracts, ABRA's essential role in vascular remodeling suggests potential relevance to arterial occlusive diseases and vascular dysfunction. The protein represents a key molecular link between cytoskeletal dynamics and transcriptional responses governing vascular cell behavior.